Is it a case of transfusion-transmitted acute HBV or reactivation of occult hepatitis B virus infection?

Transfusion Medicine

Volumn 20, Issue 4, 2010, Pages 275-

  Ozaslan, E ^a   Purnak, T ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; METHOTREXATE; PREDNISOLONE; STEROID; VIRUS DNA; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

BONE MARROW SUPPRESSION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG WITHDRAWAL; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; LETTER; LONG TERM CARE; NONHUMAN; POSTTRANSFUSION HEPATITIS; STEROID THERAPY; VIRUS REACTIVATION; ACUTE DISEASE; ADULT; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; COMPLICATION; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; HEPATITIS B, CHRONIC; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; LABORATORY DIAGNOSIS; MALE; PHYSIOLOGY; TRANSMISSION; VIREMIA; VIRUS ACTIVATION;

ACUTE DISEASE; ADULT; BLOOD DONORS; BLOOD TRANSFUSION; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; FALSE NEGATIVE REACTIONS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; VIREMIA; VIRUS ACTIVATION;

EID: 77954354020     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2010.01014.x     Document Type: Letter

References (5)

1. Barclay, S., Pol, S., Mutimer, D. et al 2008) The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting. Journal of Clinical Virology, 42, 104 115.
2. Lalazar, G., Rund, D. Shouval, D. (2007) Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. British Journal of Haematology, 136, 699 712.
3. Leung, V.K., Lee, C.K., Chau, T.N. et al. (2010) A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT. Transfusion Medicine doi: 11/j.1365-3148.2010.00997.x [Epub ahead of print].
4. Marzano, A., Angelucci, E., Andreone, P. et al 2007) Prophylaxis and treatment of hepatitis B in immunocompromised patients. Digestive and Liver Disease, 39, 397 408.
5. Raimondo, G., Allain, J.P., Brunetto, M.R. et al. (2008) Statements from the Taormina expert meeting on occult hepatitis B virus infection. Journal of Hepatology, 49, 652 657.